Next Generation News and Research

RSS

Arthrosurface launches new product for treatment of patello-femoral disease

Arthrosurface has received FDA clearance to launch its cartilage surface implant system for the treatment of patello-femoral disease.

15 Aug 2006

Belfer Foundation funds new translational cancer institute

The Arthur and Rochelle Belfer Foundation has pledged $8 million to create the Arthur and Rochelle Belfer Institute of Hematology and Medical Oncology at Weill Medical College of Cornell University.

25 Jul 2006

First study to demonstrate IVIg effective longer than a year

A purified mixture of human antibodies called intravenous immunoglobulin (IVIg) provides lasting benefits to patients with Alzheimer's disease (AD), according to researchers at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

25 Jul 2006

Women who harbor multiple HPV type infections are at higher risk for cervical lesions

The risk for developing the tissue abnormalities, or lesions, that typically precede cervical cancer is much higher for women infected with multiple genotypes of the human papillomavirus (HPV) than previously reported.

10 Jul 2006

Australian Medical Association warns of looming medical training crisis

Australian Medical Association (AMA) President, Dr Mukesh Haikerwal, has written to all Federal MPs and Senators warning them of a looming crisis in medical training.

5 Jul 2006

"Lab on a chip" test for diabetes and cardiovascular disease

A Colorado State University chemistry professor has developed a way to rapidly test blood for signs of diabetes and cardiovascular disease - methods that could save patients and physicians significant time and money.

27 Jun 2006

Markey Cancer Center receives approval to test cancer drug DB-67

Tom Burke died of colon cancer only a few years ago, but not before he helped create a new drug to fight cancer.

8 Jun 2006

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Brain tumor specialists at The University of Texas M. D. Anderson Cancer Center are poised on the brink of a new era.

10 May 2006

Gene silencing protein discovered

A team of researchers, including biologists at Washington University in St. Louis, has discovered the key role one protein plays in a major turn-off -in this case, the turning off of thousands of nearly identical genes in a hybrid plant.

8 May 2006

More effective influenza vaccine

An intranasal influenza vaccine proved to be more effective than the injectable influenza vaccine in children older than 6 months and younger than 5 years of age, according to study data presented at the annual meeting of the Pediatric Academic Societies in San Francisco.

3 May 2006

Very young infants are much more capable of organising their visual world than previously thought

Research investigating attention in infancy has revealed that, at just four months old, babies are able to organise visual information in at least three different ways, according to brightness, shape, and how close the visual elements are together (proximity).

3 May 2006

Comprehensive analysis of the human and mouse transcriptomes

An international consortium of scientists, including a team from The University of Queensland's Institute for Molecular Bioscience (IMB), is a step closer to the next generation of treatments to combat disease, after publishing a comprehensive analysis of the human and mouse transcriptomes.

3 May 2006

Medical device set to go a Storm worldwide

Intelligent Orthopaedics, an innovative orthopaedics device company backed by Staffordshire University, has entered into a long-term global distribution agreement with BSN medical, a world leading medical device company.

19 Apr 2006

Nrf2 gene findings may offer therapeutic potential for sepsis treatment

Disruption of a single gene, Nrf2, plays a critical role in regulating the body's innate immune response to sepsis and septic shock, according to a study by a research team led by Shyam Biswal, PhD, at the Johns Hopkins Bloomberg School of Public Health.

4 Apr 2006

Custom made nanoparticles will transform cancer diagnosis and treatment

Researchers have developed "custom" nanoparticles that promise to provide a more targeted and effective way of delivering anticancer drugs than conventional medications or any of the earlier attempts to fight cancer with nanoparticles.

28 Mar 2006

Researchers find environmentally friendly ways to produce more Taxol

As the effective cancer-treatment drug Taxol enters its next generation, Michigan State University announces discoveries which point to both environmentally friendly ways to produce more Taxol, and ultimately innovations to produce a more potent second-generation drug.

28 Mar 2006

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

EntreMed has announced the issuance of U.S. Patent No. 7,012,070 covering methods of treatment for a broad range of indications with its lead clinical-stage compound, 2-methoxyestradiol (2ME2).

17 Mar 2006

FDA grants Cerexa fast track designation

Cerexa has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PPI-0903, a next-generation, broad-spectrum, cephalosporin antibiotic, for the treatment of complicated skin and skin structure infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA).

17 Mar 2006

Newly discovered genetic mechanism in poultry can provide more insights to complex diseases

Scientists from Uppsala University, the Swedish University of Agricultural Sciences, and the U.S. have identified a genetic mechanism that regulates growth in chickens.

13 Mar 2006

NHS surgeons left to "pick up the pieces" after poor surgery at private treatment centres

NHS surgeons are being left to "pick up the pieces" after poor surgery at private treatment centres, warns a senior doctor in the British Medical Journal.

13 Mar 2006